<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We performed a transient bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> on rats and investigated whether feeding an aqueous extract of Mycoleptodonoides aitchisonii, an edible mushroom, affected metabolism of <z:chebi fb="0" ids="25375">monoamines</z:chebi> in the cerebral cortex, possibly protecting against ischemic damage </plain></SENT>
<SENT sid="1" pm="."><plain>Seventeen days after the surgery, concentrations of the <z:chebi fb="40" ids="18243">dopamine</z:chebi> (<z:mp ids='MP_0000273'>DA</z:mp>) metabolite <z:chebi fb="0" ids="41941">3,4-dihydroxyphenylacetic acid</z:chebi> (DOPAC) and of homovanillic acid (HVA) in the cerebral cortex of the M. aitchisonii-fed group (MV) were higher than in the control <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (CV) group </plain></SENT>
<SENT sid="2" pm="."><plain>The turnover rate of <z:mp ids='MP_0000273'>DA</z:mp>, which was indicated by (DOPAC+HVA)/<z:mp ids='MP_0000273'>DA</z:mp>, for the CV group was significantly lower than for the MV group, and the MV group value was the same rate as the sham-operated group </plain></SENT>
<SENT sid="3" pm="."><plain>These data indicate that M. aitchisonii affects the dopaminergic neuronal system following <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> damage in the cerebral cortex </plain></SENT>
</text></document>